摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-(2-fluoro-4-methylsulfonylphenylamino)-6,7-dimethoxyquinazoline | 1424336-77-5

中文名称
——
中文别名
——
英文名称
2-chloro-4-(2-fluoro-4-methylsulfonylphenylamino)-6,7-dimethoxyquinazoline
英文别名
——
2-chloro-4-(2-fluoro-4-methylsulfonylphenylamino)-6,7-dimethoxyquinazoline化学式
CAS
1424336-77-5
化学式
C17H15ClFN3O4S
mdl
——
分子量
411.841
InChiKey
FPJFSOCHBHKJKT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.59
  • 重原子数:
    27.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    90.41
  • 氢给体数:
    1.0
  • 氢受体数:
    7.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-chloro-4-(2-fluoro-4-methylsulfonylphenylamino)-6,7-dimethoxyquinazolineN-Boc-4-哌啶甲醇 在 sodium hydroxide 作用下, 以14%的产率得到Tert-butyl 4-[[4-(2-fluoro-4-methylsulfonylanilino)-6,7-dimethoxyquinazolin-2-yl]oxymethyl]piperidine-1-carboxylate
    参考文献:
    名称:
    Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists
    摘要:
    GPR119 agonist has emerged as a promising target for the treatment of type 2 diabetes. A series of novel 2,4-disubstituted quinazoline analogues was prepared and evaluated their agonistic activity against human GPR119. The analogues bearing azabicyclic amine substituents (12a, 12c and 12g) exhibited better EC50 values than that of OEA though they appeared to be partial agonists. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.12.013
  • 作为产物:
    描述:
    2-氟-4-(甲基磺酰基)苯胺2,4-二氯-6,7-二甲氧基喹唑啉 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以75%的产率得到2-chloro-4-(2-fluoro-4-methylsulfonylphenylamino)-6,7-dimethoxyquinazoline
    参考文献:
    名称:
    Synthesis and biological evaluation of novel 2,4-disubstituted quinazoline analogues as GPR119 agonists
    摘要:
    GPR119 agonist has emerged as a promising target for the treatment of type 2 diabetes. A series of novel 2,4-disubstituted quinazoline analogues was prepared and evaluated their agonistic activity against human GPR119. The analogues bearing azabicyclic amine substituents (12a, 12c and 12g) exhibited better EC50 values than that of OEA though they appeared to be partial agonists. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.12.013
点击查看最新优质反应信息